Seedadelic med corp acquisition Although I'm having trouble finding info on Seedadelic . I like this deal based on information at hand. Having 100% control of marketable properties developed by Seedadelic covering LSA and psychedelics is a excellent addition to our exsisting holdings.. if indeed LSA is similar to LSD with less side effects this research could prove to be of very high value . Interested to know more about their psychedelics programs. Solid news, rmarket should have no problems geting behind this. Dillution is reasonable. Tmed is protective of their dillution thankfully for us shareholders.. as this sector matures research needs to be broad to discover and maximize the applications and results of these potentially game changes new treatments. Liking Tmed very much in shroom space . we still might be the smallest mcap will lowest dillution of all the psychedelic plays.. great luck All